BCDA BioCardia


Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary

ESG framework mentions

In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On June 15, 2021, the Company held its Annual Meeting. Present at the Annual Meeting in person or by proxy were holders of 9,356,252 shares of the Company’s common stock, representing 55.72% of the voting power of the shares of the Company’s common stock as of April 20, 2021, the record date for the Annual Meeting, and constituting a quorum for the transaction of business. The matters before the annual meeting are described in more detail in the Company’s definitive proxy statement filed with the United States Securities and Exchange Commission on April 30, 2021.

Proposal 1 – Election of Directors. The following nominees were elected as Class II directors to serve until the 2024 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified:

NomineeVotes ForVotes AgainstAbstentionsBroker Non-votes
Jim Allen5,711,57410,30134,3783,599,999
Andrew Scott Blank5,586,904126,96542,3843,599,999

Proposal 2 – Ratification of the Appointment of Independent Registered Public Accounting Firm. The appointment of PKF San Diego, LLP as the Company’s independent registered public accounting firm for its fiscal year ending December 31, 2021 was ratified.

Votes ForVotes AgainstAbstentionsBroker Non-votes

Proposal 3 – Approval, on an Advisory Basis, of the Company’s Executive Compensation. The Company’s executive compensation was approved on an advisory basis.

Votes ForVotes AgainstAbstentionsBroker Non-votes